Rafael S. Cires-Drouet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rafael S. Cires-Drouet has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
Minerva Mayorga-Carlin
Univ Maryland, Dept Surg, College Pk, MD USA
5 shared publicationsShahab Toursavadkohi
Univ Maryland, Dept Surg, College Pk, MD USA
5 shared publicationsBartley Griffith
Department of Surgery, University of Maryland, Baltimore, MD
4 shared publicationsJohn D. Sorkin
Univ Maryland, Sch Med, Dept Med, College Pk, MD USA
4 shared publicationsKhanjan Nagarsheth
Univ Maryland, Dept Surg, College Pk, MD USA
4 shared publications- Brajesh K. Lal
Department of Vascular Surgery, University of Maryland, Baltimore, Md
3 shared publications
Latest Publications
- 13 June 2024
- Published by Elsevier in The Lancet Haematology
- Vol. 11 (8) , e555-e556
Anticoagulation in patients with inferior vena cava agenesia
- 13 June 2024
- Published by Elsevier in The Lancet Haematology
- Vol. 11 (8) , e555-e556
Anticoagulation in patients with inferior vena cava agenesia
- Open Access
- 17 August 2023
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 12 (1) , 101665
Risk factors and treatment interventions associated with incomplete thrombus resolution and pulmonary hypertension after pulmonary embolism
- 17 August 2023
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 12 (1) , 101665
Open AccessRisk factors and treatment interventions associated with incomplete thrombus resolution and pulmonary hypertension after pulmonary embolism
- 9 June 2023
- Published by SAGE Publications in Vascular Medicine
- Vol. 28 (3) , 185-187
Diversity, Equity, and Inclusion Task Force initiatives within the Society for Vascular Medicine: Current status and future challenges
- 9 June 2023
- Published by SAGE Publications in Vascular Medicine
- Vol. 28 (3) , 185-187
Diversity, Equity, and Inclusion Task Force initiatives within the Society for Vascular Medicine: Current status and future challenges
- 20 January 2023
- Published by Elsevier in Thrombosis Research
- Vol. 223, 1-6
Left ventricular systolic dysfunction during acute pulmonary embolism
- 20 January 2023
- Published by Elsevier in Thrombosis Research
- Vol. 223, 1-6
Left ventricular systolic dysfunction during acute pulmonary embolism
- 16 September 2022
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
- Vol. 37 (9) , 678-685
Clinical outcomes and echocardiographic characteristics between African American and Caucasian patients with acute pulmonary embolism
Background: Despite socioeconomic disparities, no association between clinical presentation and poor outcomes explains a higher mortality in African Americans with pulmonary embolism (PE). The objective is to identify the co-morbidities and echocardiographic characteristics associated with increased mortality in African American patients. Methods: This is a cross-sectional study of Caucasian or African American patients with PE diagnosed between October 2015 and December 2017 at University of Maryland Medical Center. The outcomes were in-hospital death, length of stay, and bleeding. Results: There were 303 African Americans and 343 Caucasians. Caucasians were older ( p = 0.007), males ( p = 0.01) with history of coronary artery revascularization (CABG ( p = 0.001), coronary stents ( p = 0.001)), trauma ( p = 0.007), and/or recent surgeries ( p = 0.0001). African Americans exhibited higher rates of diabetes ( p = 0.01), chronic kidney disease ( p = 0.0005), and smoking ( p = 0.04). Severity of PE was similar between groups and there was no difference in clot burden size. African Americans had more right ventricular strain on Computer Tomography ( p = 0.001) and echocardiogram ( p = 0.004); also, underfilled left ventricles ( p = 0.02) and higher right ventricular systolic pressures ( p = 0.001). There was no difference in hospital mortality (7.1% vs. 7.9%, p = 0.71), length of stay (13.1 ± 16.7 vs 12.8 ± 14.9, p = 0.80) and bleeding (9.0% vs.8.3%. p = 0.72). Mortality was higher in African Americans who received advanced therapies (3.8% vs. 18.8%, p = 0.02). The risk of death increased with age (OR 1.04; 95%CI 1.020–1.073) and with advanced therapies (OR 2.43; 95%CI 1.029–5.769). Conclusions: Differences in co-morbidities, radiologic findings, and echocardiographic characteristics that may contribute to higher mortality in African American patients, specifically those receiving advanced therapies.
- 16 September 2022
- Published by SAGE Publications in Phlebology: The Journal of Venous Disease
- Vol. 37 (9) , 678-685
Clinical outcomes and echocardiographic characteristics between African American and Caucasian patients with acute pulmonary embolism
Background: Despite socioeconomic disparities, no association between clinical presentation and poor outcomes explains a higher mortality in African Americans with pulmonary embolism (PE). The objective is to identify the co-morbidities and echocardiographic characteristics associated with increased mortality in African American patients. Methods: This is a cross-sectional study of Caucasian or African American patients with PE diagnosed between October 2015 and December 2017 at University of Maryland Medical Center. The outcomes were in-hospital death, length of stay, and bleeding. Results: There were 303 African Americans and 343 Caucasians. Caucasians were older ( p = 0.007), males ( p = 0.01) with history of coronary artery revascularization (CABG ( p = 0.001), coronary stents ( p = 0.001)), trauma ( p = 0.007), and/or recent surgeries ( p = 0.0001). African Americans exhibited higher rates of diabetes ( p = 0.01), chronic kidney disease ( p = 0.0005), and smoking ( p = 0.04). Severity of PE was similar between groups and there was no difference in clot burden size. African Americans had more right ventricular strain on Computer Tomography ( p = 0.001) and echocardiogram ( p = 0.004); also, underfilled left ventricles ( p = 0.02) and higher right ventricular systolic pressures ( p = 0.001). There was no difference in hospital mortality (7.1% vs. 7.9%, p = 0.71), length of stay (13.1 ± 16.7 vs 12.8 ± 14.9, p = 0.80) and bleeding (9.0% vs.8.3%. p = 0.72). Mortality was higher in African Americans who received advanced therapies (3.8% vs. 18.8%, p = 0.02). The risk of death increased with age (OR 1.04; 95%CI 1.020–1.073) and with advanced therapies (OR 2.43; 95%CI 1.029–5.769). Conclusions: Differences in co-morbidities, radiologic findings, and echocardiographic characteristics that may contribute to higher mortality in African American patients, specifically those receiving advanced therapies.
- 15 February 2022
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 10 (2) , 560-561
Time-course and Risk Factors Associated with Incomplete Thrombus Resolution in Pulmonary Embolism
- 15 February 2022
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 10 (2) , 560-561
Time-course and Risk Factors Associated with Incomplete Thrombus Resolution in Pulmonary Embolism
- 1 January 2022
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 34 (2) , 549-557
Veno-Arterial Extracorporeal Membrane Oxygenation for Pulmonary Embolism after Systemic Thrombolysis
- 1 January 2022
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 34 (2) , 549-557
Veno-Arterial Extracorporeal Membrane Oxygenation for Pulmonary Embolism after Systemic Thrombolysis
- 1 November 2021
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 9 (6) , 1382-1390
Catheter-based interventions versus medical and surgical approaches in acute pulmonary embolism
- 1 November 2021
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 9 (6) , 1382-1390
Catheter-based interventions versus medical and surgical approaches in acute pulmonary embolism
- 21 May 2021
- Published by Springer Nature in Current Surgery Reports
- Vol. 9 (6) , 1-14
Current Management of Acute Pulmonary Embolism
- 21 May 2021
- Published by Springer Nature in Current Surgery Reports
- Vol. 9 (6) , 1-14
Current Management of Acute Pulmonary Embolism
- 12 May 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (8) , 2685-2691
Ultrasound‐assisted catheter directed thrombolysis for pulmonary embolus during extracorporeal membrane oxygenation
Background Acute pulmonary embolism (PE) is the third most common cause of cardiovascular death. For patients who are hemodynamically unstable, veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) support has been shown to provide hemodynamic stability, and allow time for definitive treatment and recovery. Ultrasound‐assisted catheter directed thrombolysis (USAT) has the potential to be a safe adjunct and expedite right ventricular (RV) recovery for patients requiring VA‐ECMO for PE. Methods A review of all VA‐ECMO patients from January 2017 to September 2019 was performed. A total of 49 of these patients were cannulated due to a PE. USAT therapy was used as an adjunct in 6 (12%) of these patients. These 6 patients were given standardized USAT therapy with EKOs catheters at 1 mg/h of tissue plasminogen activator with an unfractionated heparin infusion for additional systemic anticoagulation. Outcomes, including in‐hospital death, 90‐day survival, RV recovery, and complications, were examined in the cohort of patients that received USAT as an adjunct to ECMO. Results Median age was 54 years old. Five of the six patients presented with a massive PE and had a PE severity score of Class V. One patient presented with a submassive PE with a Bova score of 2, but was cannulated to VA‐ECMO in the setting of worsening RV function. All patients demonstrated recovery of RV function, were free from in‐hospital death, and were alive at 90‐day follow‐up. Conclusion Ekosonic endovascular system therapy may be a safe and feasible adjunct for patients on VA‐ECMO for PE, and allow for survival with RV recovery with minimal complications.
- 12 May 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (8) , 2685-2691
Ultrasound‐assisted catheter directed thrombolysis for pulmonary embolus during extracorporeal membrane oxygenation
Background Acute pulmonary embolism (PE) is the third most common cause of cardiovascular death. For patients who are hemodynamically unstable, veno‐arterial extracorporeal membrane oxygenation (VA‐ECMO) support has been shown to provide hemodynamic stability, and allow time for definitive treatment and recovery. Ultrasound‐assisted catheter directed thrombolysis (USAT) has the potential to be a safe adjunct and expedite right ventricular (RV) recovery for patients requiring VA‐ECMO for PE. Methods A review of all VA‐ECMO patients from January 2017 to September 2019 was performed. A total of 49 of these patients were cannulated due to a PE. USAT therapy was used as an adjunct in 6 (12%) of these patients. These 6 patients were given standardized USAT therapy with EKOs catheters at 1 mg/h of tissue plasminogen activator with an unfractionated heparin infusion for additional systemic anticoagulation. Outcomes, including in‐hospital death, 90‐day survival, RV recovery, and complications, were examined in the cohort of patients that received USAT as an adjunct to ECMO. Results Median age was 54 years old. Five of the six patients presented with a massive PE and had a PE severity score of Class V. One patient presented with a submassive PE with a Bova score of 2, but was cannulated to VA‐ECMO in the setting of worsening RV function. All patients demonstrated recovery of RV function, were free from in‐hospital death, and were alive at 90‐day follow‐up. Conclusion Ekosonic endovascular system therapy may be a safe and feasible adjunct for patients on VA‐ECMO for PE, and allow for survival with RV recovery with minimal complications.